Episode 359: 258. Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions
https://jamanetwork.com/journals/jama/article-abstract/2822097Design, Setting, and Participants Nested case-control study using population-based linked administrative datasets among adults aged 66 ye...
3 Tammi 20255min
Episode 358: 257. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention
https://www.nejm.org/doi/full/10.1056/NEJMoa2407001ConclusionsNo participants receiving twice-yearly lenacapavir acquired HIV infection. HIV incidence with lenacapavir was significantly lower than bac...
30 Joulu 20246min
Episode 357: 256. Medications for alcohol-use disorder and follow-up after hospitalization
Allaudeen N et al. Medications for alcohol-use disorder and follow-up after hospitalization for alcohol withdrawal: A multicenter study. J Hosp Med 2024 Dec; 19:1122. (https://doi.org/10.1002/jhm.1345...
27 Joulu 20245min
Episode 356: 255. Real-world use of glucocorticoids for adults hospitalized with community-acquired pneumonia
Real‐world use of glucocorticoids and clinical outcomes in adults hospitalized with community‐acquired pneumonia on medical wards - Malecki - 2024 - Journal of Hospital Medicine - Wiley Online Library...
23 Joulu 20246min
Episode 355: 254. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension
2024 ESC guidelines propose a simple new BP categorization: Non-elevated: less than 120/70 mm Hg in the office (pharmacological treatment is not recommended). Elevated: 120 to 139/70 to 89 mm Hg (phar...
20 Joulu 20248min
Episode 354: 253. Centralized Colorectal Cancer Screening Outreach in Federally Qualified Health Centers
Question Does adding centralized mailed fecal immunochemical testing and patient navigation to usual care improve colorectal cancer (CRC) screening in US federally qualified health centers? pragmatic...
18 Joulu 20247min
Episode 353: 252. 2.4 Million to Prevent 4 Hospitalizations!
Packer M et al. Tirzepatide for heart failure with preserved ejection fraction and obesity. N Engl J Med 2024 Nov 16; [e-pub].https://doi.org/10.1056/NEJMoa2410027 In the industry-funded SUMMIT trial...
13 Joulu 202411min
Episode 352: 251. Safety of Triptans in Patients Who Have or Are at High Risk for Cardiovascular Disease
Wang Z et al. Safety of triptans in patients who have or are at high risk for cardiovascular disease: A target trial emulation. Mayo Clin Proc 2024 Nov; 99:1722. (https://doi.org/10.1016/j.mayocp.2024...
12 Joulu 20246min
